Mexico announces a 5P plan to advance personalised healthcare

Carolina Darias, the country’s Health Minister has announced that the Ministry of Health is working on a 5P Plan (link in Spanish) for the National Health System (SNS). 5Ps stand for personalized, predictive, preventive, participatory and population healthcare. The objective is to update and expand the infrastructure for health centers in order to consolidate the Mexican personalized precision healthcare. It will allow preventive measures to be adapted in an individualized way. According to Darias, this plan “will respond to the need for resources in the SNS to carry out genetic and genomic tests, as well as the storage, processing and analysis of the data derived”.

Related News

CIFS for MH2030 in Mexico – Progress Brief

The collaboration agreement with the Health Secretariat of Mexico city has focused our activities on digitization of primary care, in telehealth, and in EHR rollout to the first point of contact

All News

Willum Þór: The question remains if our healthcare system is sustainable

On January 1st, Iceland took over the Presidency of the Nordic Council of Ministers. This intergovernmental organisation plays an important role in promoting innovations, health data integration, and cooperation between all major stakeholders in the Nordic healthcare. The Icelandic Health Minister elaborates on his vision to future health in the Nordic region, the Nordic strengths, Iceland’s plans for the Presidency with regards to health innovations, and the coming collaboration with Copenhagen Institute for Futures Studies

CIFS ran an all-day session at the Week of Health and Innovation (WHINN) in Odense

Copenhagen Institute for Futures Studies ran an all-day session at the annual Week of Health and Innovation (WHINN) in Odense, Denmark. CIFS’ program attracted over 40 experts from health and data organisations. We presented strategic foresight and futures studies in the health sector, concepts that are used to reimagine the future of the health sector, such as the Humanome and decentralised clinical trials. Also, we had a panel discussion on the newly started Phase V project on decentralised clinical trials, where CIFS is a contributing partner